140 related articles for article (PubMed ID: 32044406)
1. The absence of PRDM2 involved the tumorigenesis of somatotroph adenomas through regulating c-Myc.
Wei D; Yiyuan C; Qian L; Jianhua L; Yazhuo Z; Hua G
Gene; 2020 May; 737():144456. PubMed ID: 32044406
[TBL] [Abstract][Full Text] [Related]
2. Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas.
Mayr B; Buslei R; Theodoropoulou M; Stalla GK; Buchfelder M; Schöfl C
Eur J Endocrinol; 2013 Oct; 169(4):391-400. PubMed ID: 23847328
[TBL] [Abstract][Full Text] [Related]
3. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
[TBL] [Abstract][Full Text] [Related]
4. Lower PRDM2 expression is associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.
Gao H; Wang F; Lan X; Li C; Feng J; Bai J; Cao L; Gui S; Hong L; Zhang Y
BMC Cancer; 2015 Apr; 15():272. PubMed ID: 25884948
[TBL] [Abstract][Full Text] [Related]
5. Silencing of RASSF3 by DNA hypermethylation is associated with tumorigenesis in somatotroph adenomas.
Peng H; Liu H; Zhao S; Wu J; Fan J; Liao J
PLoS One; 2013; 8(3):e59024. PubMed ID: 23555615
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
[TBL] [Abstract][Full Text] [Related]
7. The Integrated Stress Response Is Tumorigenic and Constitutes a Therapeutic Liability in Somatotroph Adenomas.
Li Z; Chen Y; Yao X; Liu Q; Zhu H; Zhang Y; Feng J; Gao H
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361871
[TBL] [Abstract][Full Text] [Related]
8. Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways.
Grzywa TM; Klicka K; Rak B; Mehlich D; Garbicz F; Zieliński G; Maksymowicz M; Sajjad E; Włodarski PK
Endocrine; 2019 Sep; 65(3):646-655. PubMed ID: 31165412
[TBL] [Abstract][Full Text] [Related]
9. Effects of miR-362 in Regulating the Proliferation, Invasion and Apoptosis of Gastric Cancer by Inhibiting the Expression of Tumor-Promoting Factor PRDM2.
Wu RM; Pei ZJ; Zhang HQ; Gao Y; Duan XY
Crit Rev Eukaryot Gene Expr; 2021; 31(1):11-21. PubMed ID: 33639051
[TBL] [Abstract][Full Text] [Related]
10. Impact of SLC20A1 on the Wnt/β‑catenin signaling pathway in somatotroph adenomas.
Li J; Dong W; Li Z; Wang H; Gao H; Zhang Y
Mol Med Rep; 2019 Oct; 20(4):3276-3284. PubMed ID: 31432167
[TBL] [Abstract][Full Text] [Related]
11. DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas.
Ben-Shlomo A; Deng N; Ding E; Yamamoto M; Mamelak A; Chesnokova V; Labadzhyan A; Melmed S
J Clin Invest; 2020 Nov; 130(11):5738-5755. PubMed ID: 32673291
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomas.
Chen Y; Li Z; Fang Q; Wang H; Li C; Gao H; Zhang Y
Int J Mol Med; 2021 Feb; 47(2):500-510. PubMed ID: 33416096
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors.
Chen Y; Gao H; Liu Q; Xie W; Li B; Cheng S; Guo J; Fang Q; Zhu H; Wang Z; Wang J; Li C; Zhang Y
Aging (Albany NY); 2020 Dec; 13(1):1422-1439. PubMed ID: 33472171
[TBL] [Abstract][Full Text] [Related]
14. Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
Lekva T; Berg JP; Lyle R; Heck A; Ringstad G; Olstad OK; Michelsen AE; Casar-Borota O; Bollerslev J; Ueland T
Endocrinology; 2013 Sep; 154(9):3331-43. PubMed ID: 23825128
[TBL] [Abstract][Full Text] [Related]
15. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
[TBL] [Abstract][Full Text] [Related]
16. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
[TBL] [Abstract][Full Text] [Related]
17. Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recovery.
Lekva T; Berg JP; Heck A; Lyngvi Fougner S; Olstad OK; Ringstad G; Bollerslev J; Ueland T
PLoS One; 2013; 8(6):e66927. PubMed ID: 23825587
[TBL] [Abstract][Full Text] [Related]
18. Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells.
Tan SX; Hu RC; Liu JJ; Tan YL; Liu WE
Int J Clin Exp Pathol; 2014; 7(5):2305-11. PubMed ID: 24966940
[TBL] [Abstract][Full Text] [Related]
19. RIZ1 and histone methylation status in pituitary adenomas.
Xue Y; Chen R; Du W; Yang F; Wei X
Tumour Biol; 2017 Jul; 39(7):1010428317711794. PubMed ID: 28718376
[TBL] [Abstract][Full Text] [Related]
20. Somatotropinomas, but not nonfunctioning pituitary adenomas, maintain a functional apoptotic RET/Pit1/ARF/p53 pathway that is blocked by excess GDNF.
Diaz-Rodriguez E; Garcia-Rendueles AR; Ibáñez-Costa A; Gutierrez-Pascual E; Garcia-Lavandeira M; Leal A; Japon MA; Soto A; Venegas E; Tinahones FJ; Garcia-Arnes JA; Benito P; Angeles Galvez M; Jimenez-Reina L; Bernabeu I; Dieguez C; Luque RM; Castaño JP; Alvarez CV
Endocrinology; 2014 Nov; 155(11):4329-40. PubMed ID: 25137025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
